The Latest Analyst Ratings for GoodRx Holdings
Portfolio Pulse from Benzinga Insights
GoodRx Holdings (NASDAQ:GDRX) has received 2 bullish and 2 indifferent analyst ratings in the last quarter. The average price target is $6.81, implying an upside from the current price of $6.5992. This average has decreased by 13.03% from the previous average price target of $7.83.
July 12, 2023 | 7:00 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
GoodRx Holdings has received mixed analyst ratings, with an average price target that suggests a potential upside.
The mixed analyst ratings indicate uncertainty about the company's future performance. However, the average price target, despite being lower than the previous one, still suggests a potential upside from the current price, which could have a positive impact on the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100